Diabetes

Previous studies have suggested that the drugs known as GLP-1s, or glucagon-like peptide-1 receptor agonists, could reduce addictions by targeting the brain’s reward pathways. But those studies have been small and often limited to one substance.

Study shows that proactive outreach by a clinical pharmacist results in safer prescribing of diabetes regimens among patients with type 2 diabetes and high hypoglycemia risk.

Damage to peripheral nerves affects around 1% of adults worldwide, according to a recent review. See how much you know about the causes, diagnosis and treatment of this common problem.

Diabetes Canada has issued multiple warnings to Canadians, including for devices that use its branding without permission.

Study compares the risk of nonarteritic anterior ischemic optic neuropathy (NAION) in new users of semaglutide versus sodium-glucose cotransporter 2 (SGLT2) inhibitors.

People with diabetes are at higher risk for complications from vaccine-preventable diseases, even if their blood glucose levels are well controlled.

Study compares the effectiveness of SGLT2i and GLP-1RA treatment for acute and chronic kidney outcomes in patients with type 2 diabetes.

Protein just got a big boost from U.S. health officials. in their latest dietary guidelines. But nutritionists say Americans are already consuming more than they need.